IRIS

CARLOMAGNO, FRANCESCA

CARLOMAGNO, FRANCESCA  

DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE  

Mostra records
Risultati 1 - 20 di 111 (tempo di esecuzione: 0.032 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Evolutionary conservation of the Eps8 gene and its mapping to human-chromosome 12q23-q24 1.1 Articolo in rivista 1994 Wong, Wt; Carlomagno, Francesca; Druck, T; Barletta, C; Croce, Cm; Heubner, K; Kraus, Mh; DI FIORE, Pp
The extent of linkage disequilibrium in four populations with distinct demographic histories 1.1 Articolo in rivista 2000 Dunning, Am; Durocher, F; Healey, Cs; Teare, Md; Mcbride, Se; Carlomagno, Francesca; Xu, Cf; Dawson, E; Rhodes, S; Ueda, S; Lai, E; Luben, Rn; VAN RENSBURG, Ej; Mannermaa, A; Kataja, V; Rennart, G; Dunhami, ; Purvis, I; Easton, D; Ponder, Ba
The Insulin Receptor Substrate (IRS)-1 recruits Phosphatidylinositol 3-Kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. 1.1 Articolo in rivista 2001 Melillo, ROSA MARINA; Carlomagno, Francesca; DE VITA, Gabriella; Formisano, Pietro; Vecchio, Giancarlo; Fusco, Alfredo; Billaud, M.; Santoro, Massimo
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 1.1 Articolo in rivista 2002 Carlomagno, Francesca; Vitagliano, Donata; Guida, Teresa; Napolitano, M.; Vecchio, Giancarlo; Fusco, Alfredo; Gazit, A.; Levitzki, A.; Santoro, Massimo
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities 1.1 Articolo in rivista 2000 Carlomagno, Francesca; Burnet, Nj; Turesson, I; Nyman, J; Peacock, Jh; Dunning, Am; Ponder, Baj; Jackson, Sp
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes. 1.1 Articolo in rivista 1998 G., Tallini; Santoro, Massimo; M., Helie; Carlomagno, Francesca; G., Salvatore; G., Chiappetta; M. L., Carcangiu; Fusco, Alfredo
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. 1.1 Articolo in rivista 1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism 1.1 Articolo in rivista 1998 Cosma, Mp; Cardone, M; Carlomagno, Francesca; Colantuoni, V.
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer 1.1 Articolo in rivista 1999 Carlomagno, Francesca; CHANG CLAUDE, J; Dunning, Am; Ponder, Baj
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) 1.1 Articolo in rivista 2003 Carlomagno, Francesca; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Efficient inhibition of RET/papillary thyroid carcinoma oncogenic kinases by 4-amino-5-(4-chloro-phenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). 1.1 Articolo in rivista 2003 Carlomagno, F; Vitagliano, D; Guida, T; Basolo, F; Castellone, Md; Melillo, ROSA MARINA; Fusco, Alfredo; Santoro, Massimo
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 1.1 Articolo in rivista 2003 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Castellone, MARIA DOMENICA; Vitagliano, Donata; Guida, Teresa; Vecchio, Giancarlo; Fusco, Alfredo
Molecular mechanisms of RET activation in human cancer. 1.1 Articolo in rivista 2002 Santoro, Massimo; Melillo, ROSA MARINA; Carlomagno, Francesca; Fusco, Alfredo; Vecchio, Giancarlo
Molecular mechanisms of RET activation in human neoplasia. 1.1 Articolo in rivista 1999 Santoro, Massimo; Carlomagno, Francesca; Melillo, ROSA MARINA; M., Billaud; Vecchio, Giancarlo; Fusco, Alfredo
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 1.1 Articolo in rivista 2002 F., Basolo; R., Giannini; C., Monaco; Melillo, ROSA MARINA; Carlomagno, Francesca; M., Pancrazi; G., Salvatore; G., Chiappetta; F., Pacini; R., Elisei; P., Miccoli; A., Pinchera; Fusco, Alfredo; Santoro, Massimo
RET ONCOGENE ACTIVATION IN HUMAN THYROID NEOPLASMS IS RESTRICTED TO THE PAPILLARY CANCER SUBTYPE 1.1 Articolo in rivista 1992 Santoro, Massimo; Carlomagno, Francesca; Hay, I. D.; Herrmann, M. A.; Grieco, M.; Melillo, ROSA MARINA; Pierotti, M. A.; Bongarzone, I.; DELLA PORTA, G.; Berger, N.; Peix, J. L.; Paulin, C.; Fabien, N.; Vecchio, Giancarlo; Jenkins, R. B.; Fusco, Alfredo
Constitutive and AP20187-induced ret activation in photoreceptors does not protect from light-induced damage 1.1 Articolo in rivista 2007 M., Allocca; U., Di Vicino; M., Petrillo; F., Carlomagno; L., Domenici; Auricchio, Alberto; Carlomagno, Francesca
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 4.2 Abstract in Atti di convegno 2012 Gnanaprakasam, Krisnamoorthy; Guida, Teresa; Visciano, Carla; Liotti, Federica; Carlomagno, Francesca; Melillo, ROSA MARINA
Antitumor effects of ZD6474, a small molecule Vascular Endothelial Growth Factor receptor tyrosine kinase inhibitor, with additional activity against Epidermal Growth Factor. 1.1 Articolo in rivista 2003 Ciardiello, F; Caputo, R; Damiano, Vincenzo; Caputo, R; Troiani, T; Vitagliano, D; Carlomagno, F; Veneziani, BIANCA MARIA; Fontanini, G; Bianco, Ar; Tortora, Giampaolo
Signalling of the Ret receptor tyrosine kinase through the c-Jun N-terminal Protein Kinases (JNKs): evidence for a divergence of the ERKs and JNKs pathways induced by Ret 1.1 Articolo in rivista 1998 Chiariello, M; Visconti, R; Carlomagno, Francesca; Melillo, ROSA MARINA; Bucci, C; DE FRANCISCIS, V; Fox, Gm; Jing, S; Coso, Om; Gutkind, Sj; Fusco, Alfredo; Santoro, M.